1. Home
  2. SNFCA vs TNXP Comparison

SNFCA vs TNXP Comparison

Compare SNFCA & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNFCA
  • TNXP
  • Stock Information
  • Founded
  • SNFCA 1965
  • TNXP 2007
  • Country
  • SNFCA United States
  • TNXP United States
  • Employees
  • SNFCA N/A
  • TNXP N/A
  • Industry
  • SNFCA Finance: Consumer Services
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNFCA Finance
  • TNXP Health Care
  • Exchange
  • SNFCA Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • SNFCA 235.5M
  • TNXP 272.0M
  • IPO Year
  • SNFCA N/A
  • TNXP N/A
  • Fundamental
  • Price
  • SNFCA $9.72
  • TNXP $35.65
  • Analyst Decision
  • SNFCA
  • TNXP Strong Buy
  • Analyst Count
  • SNFCA 0
  • TNXP 2
  • Target Price
  • SNFCA N/A
  • TNXP $585.00
  • AVG Volume (30 Days)
  • SNFCA 141.4K
  • TNXP 728.5K
  • Earning Date
  • SNFCA 08-13-2025
  • TNXP 08-15-2025
  • Dividend Yield
  • SNFCA N/A
  • TNXP N/A
  • EPS Growth
  • SNFCA 11.71
  • TNXP N/A
  • EPS
  • SNFCA 0.98
  • TNXP N/A
  • Revenue
  • SNFCA $336,074,193.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • SNFCA N/A
  • TNXP $11.66
  • Revenue Next Year
  • SNFCA N/A
  • TNXP $793.18
  • P/E Ratio
  • SNFCA $9.68
  • TNXP N/A
  • Revenue Growth
  • SNFCA 4.96
  • TNXP N/A
  • 52 Week Low
  • SNFCA $7.35
  • TNXP $6.76
  • 52 Week High
  • SNFCA $13.59
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • SNFCA 40.15
  • TNXP 52.76
  • Support Level
  • SNFCA $9.35
  • TNXP $33.30
  • Resistance Level
  • SNFCA $9.89
  • TNXP $36.20
  • Average True Range (ATR)
  • SNFCA 0.33
  • TNXP 3.01
  • MACD
  • SNFCA -0.03
  • TNXP -0.78
  • Stochastic Oscillator
  • SNFCA 12.35
  • TNXP 37.50

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: